To view or add a comment, sign in Expanding Research Are Reshaping the Hepatic Encephalopathy Market Landscape The #HepaticEncephalopathyMarket is witnessing significant transformation, driven by the rising burden of chronic liver diseases, increasing hospitalization rates, and ongoing advancements in gut microbiome-targeted and ammonia-lowering therapies
Several pharmacodynamic indicators showed that the rats in the model group had the disease characteristics of CAG, indicating that the model construction was successful
Research shows that weight loss can lead to improved running economy, meaning less energy is needed to move the body over the same distance
Clinical trials of Wegovy, Mounjaro, and Ozempic showed effectiveness, but potential side effects, including hair loss in 3-6% of patients
Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system